Article

Pharmacotherapy of suicidal behavior in bipolar disorder.

New York State Psychiatric Institute/Columbia University, Department of Neuroscience, New York 10032, USA.
Archives of Suicide Research (impact factor: 1.53). 02/2005; 9(3):237-50. DOI:10.1080/13811110590929424
Source: PubMed

ABSTRACT Patients with Bipolar Disorder (BD) are at particularly high risk for both attempted and completed suicides. The period of highest risk for completed suicide is during the 2 years following discharge from a hospitalization. To date, pharmacological studies of suicidal behavior in BD have been quite limited. While strong evidence has been found regarding the anti-suicidal effects of lithium, evidence for such properties in other commonly prescribed medications for BD, including anticonvulsants, SSRIs and anti-psychotics, has been largely unexplored. Considering the high risk of suicidal acts in patients with BD, further research on the pharmacotherapy of suicidal behavior is crucial.

0 0
 · 
0 Bookmarks
 · 
18 Views
  • Source
    Article: Antidepressants and Suicide Risk: A Comprehensive Overview
    Pompili Maurizio, Serafini Gianluca, Innamorati Marco, Ambrosi Elisa, Giordano Gloria, Girardi Paolo, Tatarelli Roberto, Lester David
    [show abstract] [hide abstract]
    ABSTRACT: The annual worldwide suicide rate currently averages approximately 13 per 100,000 individuals per year (0.013% per year), with higher average rates for men than for women in all but a few countries, very low rates in children, and relatively high rates in elderly men. Suicide rates vary markedly between countries, reflecting in part differences in case-identification and reporting procedures. Rates of attempted suicide in the general population average 20–30 times higher than rates of completed suicide, but are probably under-reported. Research on the relationship between pharmacotherapy and suicidal behavior was rare until a decade ago. Most ecological studies and large clinical studies have found that a general reduction in suicide rates is significantly correlated with higher rates of prescribing modern antidepressants. However, ecological, cohort and case-control studies and data from brief, randomized, controlled trials in patients with acute affective disorders have found increases, particularly in young patients and particularly for the risk of suicide attempts, as well as increases in suicidal ideation in young patients. whether antidepressants are associated with specific aspects of suicidality (e.g., higher rates of completed suicide, attempted suicide and suicidal ideation) in younger patients with major affective disorders remains a highly controversial question. In light of this gap this paper analyzes research on the relationship between suicidality and antidepressant treatment.
    Pharmaceuticals. 01/2010;
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

anti-suicidal effects
 
BD
 
Bipolar Disorder
 
highest risk
 
lithium
 
patients
 
pharmacotherapy
 
prescribed medications
 
strong evidence
 
suicidal acts
 
suicidal behavior
 
suicides
 

Maria A Oquendo